Kalpesh Barot in Orlando, Florida

Home Florida Orlando

Kalpesh Barot has Hematology/oncology as his primary medical specialty. Their primary office is: 922 Lucerne Ter in Orlando, Florida.

They're a part of the: Thomas J Katta Md Pa medical group which has around 4 members. You can call their office at 407-426-8660 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2003 (around 21 years of experience). They are listed as doing telehealth appointments.

Kalpesh B Barot Office Phone and Directions

Kalpesh Barot
Thomas J Katta Md Pa
922 Lucerne Ter
Orlando, Florida 32806
407-426-8660

Patient Ratings
Please rate your experience with Kalpesh Barot below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 407-426-8660

Enter a starting address:

Healthcare Info for Kalpesh Barot

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Kalpesh Barot is listed as: Hematology/oncology
Approximate Years of Experience: 21
PAC (PECOS ID)#: 4385827757
NPI #: 1760686059
NPI Created On: 06/12/2007
NPI Last Updated Listed as: 02/04/2011
Primary Taxonomy Code: 390200000X
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Celtic Insurance Company
Blue Cross Blue Shield
Oscar Insurance Company of Florida
Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Spanish, Hindi, Gujarati.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Blood test, clotting time
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $61

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655407

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655409

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655411

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655415

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655413

Being Disputed:: No

Product Related: No

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655417

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655419

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655421

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655425

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788655423

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Hematology/oncology Professionals in Orlando

1.
Dennis Borrero Ramos

2501 N Orange Ave
Orlando, FL
Florida Hospital Medical Group Inc

2.
Kristi George

6535 Nemours Pkwy
Orlando, FL
The Nemours Foundation

3.
Brian Parkin

601 E Rollins St
Orlando, FL
Florida Hospital Medical Group Inc

4.
Dorothea Douglas

6535 Nemours Pkwy
Orlando, FL
The Nemours Foundation

5.
Philip Pancari

2415 N Orange Ave
Orlando, FL
Florida Hospital Medical Group Inc

6.
Geethanja Akula MD

70 W Gore Street
Orlando, FL
Florida Cancer Specialists And Research Institute, Llc

Providers in Thomas J Katta Md Pa

1.Kalpesh Barot

922 Lucerne Ter
Orlando Fl 32806-1013
Thomas J Katta Md Pa
Hematology/oncology

2.Carlos Gadea

922 Lucerne Ter
Orlando Fl 32806-1013
Thomas J Katta Md Pa
Hematology/oncology

3.Thomas Katta Md

922 Lucerne Ter
Orlando Fl 32806-1013
Thomas J Katta Md Pa
Hematology/oncology

4.Sarah Katta

922 Lucerne Ter
Orlando Fl 32806-1013
Thomas J Katta Md Pa
Hematology/oncology

View all 4 members of Thomas J Katta Md Pa medical group